Pro Share Advisors LLC Vericel Corp Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Vericel Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,019 shares of VCEL stock, worth $762,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,019

Previous 10,351 25.78%

Holding current value

$762,132

Previous $474,000 16.03%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$42.25 - $53.56 $112,723 - $142,898	2,668 Added 25.78%	13,019 $550,000
Q2 2024 Aug 13, 2024	SELL	$41.71 - $52.9 $109,864 - $139,338	-2,634 Reduced 20.28%	10,351 $474,000
Q1 2024 May 08, 2024	BUY	$32.52 - $52.33 $32,357 - $52,068	995 Added 8.3%	12,985 $675,000
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $146,321 - $175,917	4,743 Added 65.45%	11,990 $426,000
Q3 2023 Nov 13, 2023	SELL	$31.69 - $39.25 $5,989 - $7,418	-189 Reduced 2.54%	7,247 $242,000
Q2 2023 Aug 10, 2023	BUY	$29.0 - $38.37 $17,197 - $22,753	593 Added 8.67%	7,436 $279,000
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $163,205 - $214,459	6,843 New	6,843 $200,000
Q2 2022 Aug 01, 2022	SELL	$22.88 - $39.45 $236,785 - $408,268	-10,349 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$31.69 - $43.29 $40,531 - $55,367	-1,279 Reduced 11.0%	10,349 $395,000
Q4 2021 Feb 08, 2022	BUY	$35.2 - $52.6 $157,203 - $234,911	4,466 Added 62.36%	11,628 $457,000
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $285,516 - $368,060	-6,160 Reduced 46.24%	7,162 $350,000
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $8,779 - $12,612	-186 Reduced 1.38%	13,322 $699,000
Q1 2021 May 14, 2021	BUY	$30.93 - $59.48 $106,275 - $204,373	3,436 Added 34.11%	13,508 $750,000
Q4 2020 Feb 09, 2021	BUY	$18.53 - $31.5 $186,634 - $317,268	10,072 New	10,072 $311,000

Others Institutions Holding VCEL

# of Institutions

279

Shares Held

48.7M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Vericel Corp Transaction History